Antioxidant dietary status and genetic cardiovascular risk, or how an adequate intake of a-tocopherol, selenium, taurine, magnesium and various other natural antioxidants may overcome the deleterious metabolic consequences related to the E4-4 type of apolipoprotein E.
Durlach
J
J
Hôp. St. Vincent-de-Paul, Paris, France.
Durlach
A
A
Durlach
V
V
D000975:Antioxidants / Q000494:pharmacology*; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D001161:Arteriosclerosis / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics*; D004032:Diet; D005387:Finland; D006801:Humans; D008274:Magnesium / Q000494:pharmacology*; D009664:Norway; D013654:Taurine / Q000494:pharmacology; D014810:Vitamin E / Q000494:pharmacology
D000975:Antioxidants; D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D014810:Vitamin E; D013654:Taurine; D008274:Magnesium